Seidenfeld A M, Smythe H A, Ogryzlo M A, Urowitz M B, Dotten D A
J Rheumatol. 1984 Oct;11(5):586-7.
Acute leukemia is described in two patients treated with cytotoxic agents for a destructive, seropositive rheumatoid arthritis. Both patients had received longterm azathioprine therapy. In addition, one patient had been treated with cyclophosphamide, the other with melphalan. Chromosomal abnormalities were noted in both patients. Studies in one patient included colony forming units, ferrokinetics, electron microscopy of bone marrow, and autopsy examination. All reports of acute leukemia associated with cytostatic drugs in the literature to date are reviewed and the possible mechanisms discussed. It is suggested that patients with rheumatoid arthritis treated with azathioprine and alkylating agents may have an increased risk of developing a therapy-related acute leukemia.
两名因破坏性血清阳性类风湿性关节炎接受细胞毒性药物治疗的患者被诊断出患有急性白血病。两名患者均长期接受硫唑嘌呤治疗。此外,一名患者曾接受环磷酰胺治疗,另一名接受美法仑治疗。两名患者均发现染色体异常。对其中一名患者的研究包括集落形成单位、铁动力学、骨髓电子显微镜检查和尸检。本文回顾了迄今为止文献中所有与细胞抑制药物相关的急性白血病报告,并讨论了可能的机制。研究表明,接受硫唑嘌呤和烷化剂治疗的类风湿性关节炎患者发生治疗相关急性白血病的风险可能会增加。